Crossing the blood–brain barrier: recent advances in drug delivery to the brain

MM Patel, BM Patel - CNS drugs, 2017 - Springer
CNS disorders are on the rise despite advancements in our understanding of their
pathophysiological mechanisms. A major hurdle to the treatment of these disorders is the …

Tight junction modulation of the blood brain barrier: CNS delivery of small molecules

C Greene, M Campbell - Tissue barriers, 2016 - Taylor & Francis
The blood brain barrier (BBB) represents a major obstacle for targeted drug delivery to the
brain for the treatment of central nervous system (CNS) disorders. Significant advances in …

Tight junction proteins at the blood–brain barrier: far more than claudin-5

P Berndt, L Winkler, J Cording… - Cellular and molecular …, 2019 - Springer
At the blood–brain barrier (BBB), claudin (Cldn)-5 is thought to be the dominant tight junction
(TJ) protein, with minor contributions from Cldn3 and-12, and occludin. However, the BBB …

A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment

D Wang, C Wang, L Wang, Y Chen - Drug delivery, 2019 - Taylor & Francis
Glioblastoma (GBM) is the most common and lethal primary brain tumor which is highly
resistant to conventional radiotherapy and chemotherapy, and cannot be effectively …

A versatile lab-on-a-chip tool for modeling biological barriers

FR Walter, S Valkai, A Kincses, A Petneházi… - Sensors and Actuators B …, 2016 - Elsevier
Abstract Models of biological barriers are important to study physiological functions,
transport mechanisms, drug delivery and pathologies. However, there are only a few …

Penetration of the SARS-CoV-2 spike protein across the blood–brain barrier, as revealed by a combination of a human cell culture model system and optical …

D Petrovszki, FR Walter, JP Vigh, A Kocsis, S Valkai… - Biomedicines, 2022 - mdpi.com
Since the outbreak of the global pandemic caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), several clinical aspects of the disease have come into attention. Besides its …

Modulating the blood–brain barrier: a comprehensive review

R Whelan, GC Hargaden, AJS Knox - Pharmaceutics, 2021 - mdpi.com
The highly secure blood–brain barrier (BBB) restricts drug access to the brain, limiting the
molecular toolkit for treating central nervous system (CNS) diseases to small, lipophilic …

Cyclodextrins, blood–brain barrier, and treatment of neurological diseases

M Vecsernyés, F Fenyvesi, I Bácskay, MA Deli… - Archives of medical …, 2014 - Elsevier
Biological barriers are the main defense systems of the homeostasis of the organism and
protected organs. The blood–brain barrier (BBB), formed by the endothelial cells of brain …

Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

EJ Patharapankal, AL Ajiboye, C Mattern, V Trivedi - Pharmaceutics, 2023 - mdpi.com
In recent years, there have been a growing number of small and large molecules that could
be used to treat diseases of the central nervous system (CNS). Nose-to-brain delivery can …

Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain

W Neuhaus, A Piontek, J Protze, M Eichner… - Biomaterials, 2018 - Elsevier
The blood-brain barrier (BBB) prevents entry of neurotoxic substances but also that of drugs
into the brain. Here, the paracellular barrier is formed by tight junctions (TJs) with claudin-5 …